Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1986 Nov;61(11):1076–1083. doi: 10.1136/adc.61.11.1076

Respiratory distress syndrome and inositol supplementation in preterm infants.

M Hallman, A L Järvenpää, M Pohjavuori
PMCID: PMC1778095  PMID: 3539028

Abstract

We report a randomised double blind trial of myo-inositol (inositol) supplementation for 10 days in 74 preterm infants with a birth weight less than 2000 g (mean gestational age 29.5 weeks and mean birth weight 1266 g). All infants required artificial ventilation for treatment of respiratory distress syndrome. Inositol (120-160 mg/kg/day) was administered by the ingastric or intravenous route. The 37 infants who received inositol supplementation required less mechanical ventilation during days 4-10, had less failures of indomethacin to close ductus arteriosus, and had less deaths or bronchopulmonary dysplasia, or both, than the infants treated with placebo. There were no detectable adverse effects. These preliminary results suggest that inositol is an important nutrient in immature preterm infants.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baden M., Bauer C. R., Colle E., Klein G., Taeusch H. W., Jr, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics. 1972 Oct;50(4):526–534. [PubMed] [Google Scholar]
  2. Beppu O. S., Clements J. A., Goerke J. Phosphatidylglycerol-deficient lung surfactant has normal properties. J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):496–502. doi: 10.1152/jappl.1983.55.2.496. [DOI] [PubMed] [Google Scholar]
  3. Bleasdale J. E., Maberry M. C., Quirk J. G. Myo-inositol homeostasis in foetal rabbit lung. Biochem J. 1982 Jul 15;206(1):43–52. doi: 10.1042/bj2060043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blumberg A., Esslen E., Bürgi W. Myoinositol--a uremic neurotoxin? Nephron. 1978;21(4):186–191. doi: 10.1159/000181392. [DOI] [PubMed] [Google Scholar]
  5. Bromberger P., Hallman M. Myoinositol in small preterm infants: relationship between intake and serum concentration. J Pediatr Gastroenterol Nutr. 1986 May-Jun;5(3):455–458. doi: 10.1097/00005176-198605000-00021. [DOI] [PubMed] [Google Scholar]
  6. Burton L. E., Wells W. W. myo-Inositol deficiency: studies on the mechanism of lactation-dependent fatty liver formation in the rat. J Nutr. 1979 Aug;109(8):1483–1491. doi: 10.1093/jn/109.8.1483. [DOI] [PubMed] [Google Scholar]
  7. Chu S. H., Hegsted D. M. Myo-inositol deficiency in gerbils: changes in phospholipid composition of intestinal microsomes. J Nutr. 1980 Jun;110(6):1217–1223. doi: 10.1093/jn/110.6.1217. [DOI] [PubMed] [Google Scholar]
  8. Dillard R. G. Mean airway pressure calculation. J Pediatr. 1980 Sep;97(3):506–507. doi: 10.1016/s0022-3476(80)80229-0. [DOI] [PubMed] [Google Scholar]
  9. Edwards D. K., Hilton S. V., Merritt T. A., Hallman M., Mannino F., Boynton B. R. Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology. 1985 Nov;157(2):329–334. doi: 10.1148/radiology.157.2.3840268. [DOI] [PubMed] [Google Scholar]
  10. Greene D. A., De Jesus P. V., Jr, Winegrad A. I. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest. 1975 Jun;55(6):1326–1336. doi: 10.1172/JCI108052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hallman M. Effect of extracellular myo-inositol on surfactant phospholipid synthesis in the fetal rabbit lung. Biochim Biophys Acta. 1984 Aug 15;795(1):67–78. doi: 10.1016/0005-2760(84)90105-x. [DOI] [PubMed] [Google Scholar]
  12. Hallman M., Enhorning G., Possmayer F. Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr Res. 1985 Mar;19(3):286–292. doi: 10.1203/00006450-198503000-00006. [DOI] [PubMed] [Google Scholar]
  13. Hallman M., Merritt T. A., Jarvenpaa A. L., Boynton B., Mannino F., Gluck L., Moore T., Edwards D. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr. 1985 Jun;106(6):963–969. doi: 10.1016/s0022-3476(85)80253-5. [DOI] [PubMed] [Google Scholar]
  14. Hallman M., Saugstad O. D., Porreco R. P., Epstein B. L., Gluck L. Role of myoinositol in regulation of surfactant phospholipids in the newborn. Early Hum Dev. 1985 Jan;10(3-4):245–254. doi: 10.1016/0378-3782(85)90055-6. [DOI] [PubMed] [Google Scholar]
  15. Hallman M., Slivka S., Wozniak P., Sills J. Perinatal development of myoinositol uptake into lung cells: surfactant phosphatidylglycerol and phosphatidylinositol synthesis in the rabbit. Pediatr Res. 1986 Feb;20(2):179–185. doi: 10.1203/00006450-198602000-00018. [DOI] [PubMed] [Google Scholar]
  16. Hallman M., Teramo K. Measurement of the lecithin/sphingomyelin ratio and phosphatidylglycerol in aminotic fluid: an accurate method for the assessment of fetal lung maturity. Br J Obstet Gynaecol. 1981 Aug;88(8):806–813. doi: 10.1111/j.1471-0528.1981.tb01307.x. [DOI] [PubMed] [Google Scholar]
  17. Holub B. J. The nutritional significance, metabolism, and function of myo-inositol and phosphatidylinositol in health and disease. Adv Nutr Res. 1982;4:107–141. doi: 10.1007/978-1-4613-9934-6_5. [DOI] [PubMed] [Google Scholar]
  18. Lewin L. M., Melmed S., Passwell J. H., Yannai Y., Brish M., Orda S., Boichis H., Bank H. Myoinositol in human neonates: serum concentrations and renal handling. Pediatr Res. 1978 Jan;12(1):3–6. doi: 10.1203/00006450-197801000-00002. [DOI] [PubMed] [Google Scholar]
  19. Liggins G. C., Howie R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972 Oct;50(4):515–525. [PubMed] [Google Scholar]
  20. Michell R. H. Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta. 1975 Mar 25;415(1):81–47. doi: 10.1016/0304-4157(75)90017-9. [DOI] [PubMed] [Google Scholar]
  21. Morley C. J., Bangham A. D., Miller N., Davis J. A. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1981 Jan 10;1(8211):64–68. doi: 10.1016/s0140-6736(81)90002-7. [DOI] [PubMed] [Google Scholar]
  22. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  23. Ogasa K., Kuboyama M., Kiyosawa I., Suzuki T., Itoh M. The content of free and bound inositol in human and cow's milk. J Nutr Sci Vitaminol (Tokyo) 1975;21(2):129–135. doi: 10.3177/jnsv.21.129. [DOI] [PubMed] [Google Scholar]
  24. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529–534. doi: 10.1016/s0022-3476(78)80282-0. [DOI] [PubMed] [Google Scholar]
  25. Wilkinson A., Jenkins P. A., Jeffrey J. A. Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency. Lancet. 1985 Aug 10;2(8450):287–291. doi: 10.1016/s0140-6736(85)90346-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES